References
- World Health Organization. Manual for Surveillance of Human Transmissible Spongiform Encephalopathies Including Variant Creutzfeldt Jakob Disease 2003; Geneva World Health Organization
- Wleser HG, Schindler K, Zumsteg D. EEG in Creutzfeldt-Jakob disease. Clinical Neurophysiology 2006; 117:935 - 951
- Velasquez-Perez L, Rembao-Bojorquez J, Guevara J, Guadarrama-Torres RM, Trejo-Contreras A. Creutzfeldt-Jakob Disease in Mexico. Neuropathology 2007; 27:419 - 428
- Calderón-Garcidueñas AL, Sagastegui-Rodriguez JA, Canales-Ibarra C, Farías-García R. A case of Creutzfeldt-Jakob in the Mexican north-east and review of current concepts on prion disease. Gac Med Mex 2001; 137:589 - 594
- Martinez-Barros M, Ramos Peek J, Vega R, Escobar A. La enfermedad de Creutzfeldt-Jakob. Correlación clínica, electrofisiológica e histopatológica. Gac Med Mex 1996; 131:591 - 596
- Kltamoto T. Slow Virus Infection Research Comitte. Slow Virus Infection Research Committte. Clinical Stages of Creutzfeldt-Jakob disease. Annual report of the Slow Virus Infection Research Committee 1999; Tokyo The Ministry of Health and Welfare of Japan 9
- Schröter A, Zerr I, Henkel K, Tschampa HJ, Finkenstaedt M, Poser S. Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob Disease. Arch Neurol 2000; 57:1751 - 1757
- Shiga Y, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004; 10:443 - 449
- Zeidler M, Green A. Advances in diagnosing Creutzfeldt-Jakob disease with MRI and CSF 14-3-3-protein analysis. Neurology 2004; 63:410 - 441
- Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS, et al. Analysis of EEG and CSF 14-3-3-proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55:811 - 815
- Kellar JA, Lees VW. Risk management of the transmissible spongiform encephalopthies in North America. Rev Sci Tech 2003; 22:201 - 225